AbCellera Biologics Inc. (ABCL)
undefined
undefined%
At close: undefined
2.80
-0.18%
After-hours Dec 13, 2024, 07:55 PM EST

AbCellera Biologics Inc. Forcast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for ABCL stock have an median target of 8.5, with a low estimate of 5 and a high estimate of 12. The median target predicts an increase of 202.49% from the current stock price of 2.81.

Analyst Consensus: Buy
Target Low Average Median High
Price $5 $8.5 $8.5 $12
Change 77.94% 202.49% 202.49% 327.05%

AI Analyst Report

Stifel maintains a Buy rating on AbCellera Biologi... Unlock content with Pro Subscription

Updated Nov 05, 2024

Rating Feb 24May 24Jul 24Aug 24Nov 24
Strong Buy 00000
Buy 21101
Hold 00011
Sell 00000
Strong Sell 00000
Total 2 1 1 1 2

Financial Forecast this Year

Revenue This Year
33.48M
from 38.02M
Increased by -11.9%
Revenue Next Year
50.48M
from 33.48M
Increased by 50.7%
EPS This Year
-0.46
from -0.51
Increased by 9.8%
EPS Next Year
-0.65
from -0.46
Increased by -41.3%